Jakafi in Patients with Polycythemia Vera
A Case-Based Presentation: Jakafi® (ruxolitinib) in Patients with Polycythemia Vera who have an Inadequate Response to Hydroxyurea Featured Speaker:
Register by: Thursday, November 14, 2019 |
|
A Case-Based Presentation: Jakafi® (ruxolitinib) in Patients with Polycythemia Vera who have an Inadequate Response to Hydroxyurea Featured Speaker:
Register by: Thursday, November 14, 2019 |
|